FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:704-705 August 26, 1999 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Raphael Dolin, Henry Masur, and Michael S. Saag. 864 pp., illustrated. New York, Churchill Livingstone, 1999. $150. ISBN 0-443-07592-1.

The treatment of patients with AIDS is a maturing specialty that is now moving into its third decade. For this reason, it is timely to note the appearance of a work dedicated exclusively to therapies for the suppression of viral replication and for the opportunistic infections and cancers associated with AIDS. These treatments consist of increasingly complex regimens that involve a high risk of deleterious drug interactions.

First editions of any work reflect prodigious effort, and the lengthy process of preparation often results in some material's being outdated by the time of publication. In this work, however, the sections on . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.